BioSpace News Archive

Drug Development

Amgen New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential Advantages Over Standard of Care

June 7, 2010
·
16 min read
Drug Development

Successful Phase III Clinical Trial Results Reported for NovoCure Ltd.'s Novel Medical Device for Treatment of Recurrent Glioblastoma

June 7, 2010
·
4 min read
St. Jude Children’s Research Hospital: Non-Melanoma Skin Cancer May Help Identify Survivors at Increased Risk for Future Cancers

June 7, 2010
·
3 min read
Drug Development

Pfizer Inc. Phase 3 Study Showed MACUGEN(R) Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema

June 7, 2010
·
9 min read
Drug Development

Poniard Pharmaceuticals, Inc. Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer

June 7, 2010
·
8 min read
Drug Development

Onyx Pharmaceuticals, Inc.'s Carfilzomib Continues to Demonstrate Encouraging Results in Ongoing Phase 2 Multiple Myeloma Study

June 7, 2010
·
8 min read
Drug Development

Novartis Pharmaceuticals Corporation Drug Afinitor(R) First to Shrink SEGA Brain Tumors in Children and Adults With Tuberous Sclerosis

June 7, 2010
·
13 min read
Pharm Country

Clinical and Laboratory Standards Institute Publishes Procedures for the Handling and Processing of Blood Specimens for Common Laboratory Tests

June 7, 2010
·
1 min read
FDA

Derma Sciences, Inc. Receives CE Mark for ALGICELL(R) Ag

June 7, 2010
·
4 min read
FDA

Celera Corporation Announces CE Mark for KIF6 Test

June 7, 2010
·
5 min read